BioMarin announces Alesta acquisition charges
- Acquired IPR&D charge of $283M for Q3 2026
- Estimated EPS impact of $1.50 for Q3 2026
- Full-year 2026 charges expected at $320M
BMRN
BIOMARIN PHARMACEUTICAL INC SEC filings
Every EDGAR filing for BIOMARIN PHARMACEUTICAL INC (BMRN), newest first, with AI summaries and stories.
- Ticker
- BMRN
- CIK
- 1048477
- Sector
- Biotech and pharma
- Latest filing
- Oct 8
Next: earnings expected ~Nov 2 · 10-Q expected ~Nov 3 (deadline Nov 9)
Insider activity
No open-market insider buys in the last 30 days.
Also: 1 grant or exercise.
Filings
8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 4BIOMARIN PHARMACEUTICAL INCBMRNLIVE Gregory R Friberg, insider filing for BMRN
Gregory R Friberg
8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 4BIOMARIN PHARMACEUTICAL INCBMRNLIVE 2 insider filings
Robert M Plenge, insider filing for BMRN
Show all 2
- 4Insider filing for BMRN
- 3New insider at BMRN
Robert M Plenge, reporting
8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 4BIOMARIN PHARMACEUTICAL INCBMRNLIVE George Eric Davis, insider filing for BMRN
George Eric Davis, reporting
144BIOMARIN PHARMACEUTICAL INCBMRNLIVE George Eric Davis, planned sale of BMRN shares
George Eric Davis, reporting
8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE S-8BIOMARIN PHARMACEUTICAL INCBMRNLIVE 10-QBIOMARIN PHARMACEUTICAL INCBMRNLIVE 8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 8-K/ABIOMARIN PHARMACEUTICAL INCBMRNLIVE 4BIOMARIN PHARMACEUTICAL INCBMRNLIVE 9 insider filings
Athena Countouriotis, insider filing for BMRN
Show all 9
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
Athena Countouriotis, reporting
8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 4BIOMARIN PHARMACEUTICAL INCBMRNLIVE Cristin Hubbard, insider filing for BMRN
Cristin Hubbard, reporting
4BIOMARIN PHARMACEUTICAL INCBMRNLIVE Gregory R Friberg, insider filing for BMRN
Gregory R Friberg, reporting
144BIOMARIN PHARMACEUTICAL INCBMRNLIVE Gregory R Friberg, planned sale of BMRN shares
Gregory R Friberg, reporting
10-QBIOMARIN PHARMACEUTICAL INCBMRNLIVE 8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE SCHEDULE 13GBIOMARIN PHARMACEUTICAL INCBMRNLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE ARSBIOMARIN PHARMACEUTICAL INCBMRNLIVE DEFA14ABIOMARIN PHARMACEUTICAL INCBMRNLIVE DEF 14ABIOMARIN PHARMACEUTICAL INCBMRNLIVE SCHEDULE 13G/ABIOMARIN PHARMACEUTICAL INCBMRNLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
4BIOMARIN PHARMACEUTICAL INCBMRNLIVE 4 insider filings
George Eric Davis, insider filing for BMRN
Show all 4
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
George Eric Davis, reporting
4BIOMARIN PHARMACEUTICAL INCBMRNLIVE 2 insider filings
Cristin Hubbard, insider filing for BMRN
Show all 2
- 4Insider filing for BMRN
- 4Insider filing for BMRN
Cristin Hubbard, reporting
4BIOMARIN PHARMACEUTICAL INCBMRNLIVE 4 insider filings
Charles Greg Guyer, insider filing for BMRN
Show all 4
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
- 4Insider filing for BMRN
Charles Greg Guyer, reporting
8-KBIOMARIN PHARMACEUTICAL INCBMRNLIVE 4BIOMARIN PHARMACEUTICAL INCBMRNLIVE Charles Greg Guyer, insider filing for BMRN
Charles Greg Guyer, reporting